✦ LIBER ✦

A safety and efficacy study of recombinant human interleukin-10 (rHuIL-10) treatment in 329 patients with chronic active Crohn's disease (CACD)

✍ Scribed by Schreiber, S.; Fedorak, R.N.; Nielsen, O.H.; Wild, G.; Williams, N.C.; Jacyna, M.; Lashner, B.A.; Cohard, M.; Kilian, A.; Lebeaut, A.; Hanauer, S.B.

Book ID: 123098331
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 178 KB
Volume: 114
Category: Article
ISSN: 0016-5085
DOI: 10.1016/S0016-5085(98)84394-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and Efficacy of Recombinant Human

Safety and Efficacy of Recombinant Human Interleukin 10 in Chronic Active Crohn's Disease

✍ Stefan Schreiber*; Richard N. Fedorak†; Ole Haagen Nielsen§; Gary Wild‖; C.Noel 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 206 KB

New insights into the pathogenesis of an

New insights into the pathogenesis of anemia of chronic diseases: Induction of ferritin synthesis and development of anemia during recombinant human interleukin-10 (rHuIL-10) treatment of chronic active Crohn's disease (CACD)

✍ Tilg, H.; Kaser, A.; Gregor, M.; van Deventer, S.; Koningsberger, J.C.; Abreu, L 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Recombinant human interleukin-10 (rHuIL-

Recombinant human interleukin-10 (rHuIL-10) therapy in steroid-refractory chronic active Crohn's disease (CACD): Induction of neopterin, a degradation product of the pteridine pathway regulated by interferon-gamma

✍ Tilg, H.; Kaser, A.; Propst, A.; Schreiber, S.; Gregor, M.; van Deventer, S.; Ko 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 178 KB

Recombinant Human Interleukin 10 in the

Recombinant Human Interleukin 10 in the Treatment of Patients With Mild to Moderately Active Crohn's Disease

✍ Richard N. Fedorak*; Alfred Gangl†; Charles O. Elson§; Paul Rutgeerts‖; Stefan S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 238 KB

Preliminary evaluation of safety and act

Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease

✍ Bruce E. Sands*; Simmy Bank‡; Charles A. Sninsky§; Malcolm Robinson∥; Seymour Ka 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 101 KB

PO10-TU-49 Efficacy, safety and tolerabi

PO10-TU-49 Efficacy, safety and tolerability of natalizumab in Turkish multiple sclerosis patients with high disease activity: a prospective, multicentre study

✍ M. Eraksoy; G. Akman-Demır; K. Agan; D. Günal; Ö. Us; S. Saip; N.O. Demirci; M. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB